178 related articles for article (PubMed ID: 36371387)
1. ADCK1 is a potential therapeutic target of osteosarcoma.
Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
[TBL] [Abstract][Full Text] [Related]
2. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
Han Q; Yan P; Song R; Liu F; Tian Q
Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
[TBL] [Abstract][Full Text] [Related]
3. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
[TBL] [Abstract][Full Text] [Related]
4. Identification of Gαi3 as a promising target for osteosarcoma treatment.
Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
[TBL] [Abstract][Full Text] [Related]
5. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
[TBL] [Abstract][Full Text] [Related]
6. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
[TBL] [Abstract][Full Text] [Related]
7. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
8. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
[TBL] [Abstract][Full Text] [Related]
10. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
[TBL] [Abstract][Full Text] [Related]
11. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
[TBL] [Abstract][Full Text] [Related]
12. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.
Zhang J; Yin DP; Zhang Y; Zhang JN; Yang Y; Zhang ZQ; Zhou L; Lv Y; Huang HW; Cao C
Int J Biol Sci; 2022; 18(15):5667-5680. PubMed ID: 36263185
[TBL] [Abstract][Full Text] [Related]
13. TIMM44 is a potential therapeutic target of human glioma.
Guo YZ; Chen G; Huang M; Wang Y; Liu YY; Jiang Q; Cao C; Liu F
Theranostics; 2022; 12(17):7586-7602. PubMed ID: 36438483
[TBL] [Abstract][Full Text] [Related]
14. The requirement of the mitochondrial protein NDUFS8 for angiogenesis.
Xiong QW; Jiang K; Shen XW; Ma ZR; Yan XM; Xia H; Cao X
Cell Death Dis; 2024 Apr; 15(4):253. PubMed ID: 38594244
[TBL] [Abstract][Full Text] [Related]
15. Dual mTORC1/2 inhibition by INK-128 results in antitumor activity in preclinical models of osteosarcoma.
Jiang H; Zeng Z
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):255-61. PubMed ID: 26514724
[TBL] [Abstract][Full Text] [Related]
16. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
[TBL] [Abstract][Full Text] [Related]
17. mTOR: An attractive therapeutic target for osteosarcoma?
Ding L; Congwei L; Bei Q; Tao Y; Ruiguo W; Heze Y; Bo D; Zhihong L
Oncotarget; 2016 Aug; 7(31):50805-50813. PubMed ID: 27177330
[TBL] [Abstract][Full Text] [Related]
18. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
20. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma.
Han QC; Zhang XY; Yan PH; Chen SF; Liu FF; Zhu YR; Tian Q
Cell Death Discov; 2021 Dec; 7(1):393. PubMed ID: 34907167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
